Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6134750

COCCCCCCCN1CCN(c2ccc(-c3nnc(N)s3)cc2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 3/20 0.42
ALDH1A1 P00352 1/20 0.40
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39
TSHR P16473 2/20 0.39
USP28 Q96RU2 1/20 0.39
USP25 Q9UHP3 1/20 0.39
DRD3 P35462 2/20 0.39
CSNK2A2 P19784 2/20 0.38
CSNK2A1 P68400 2/20 0.38
CSNK2B P67870 1/20 0.38
ABCB1 P08183 1/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 1/20 0.38
DRD4 P21917 3/20 0.38
DRD2 P14416 2/20 0.38
HRH3 Q9Y5N1 2/20 0.38
QPCT Q16769 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6134403 1.00 USP2 (0.42) USP2ALDH1A1HTR2AHTR2CHTR2B
SCHEMBL7174851 0.91 RAB9A (0.45) USP2ALDH1A1HTR2AHTR2CHTR2B
Trifluoroacetic Acid SCHEMBL6133865 0.86 MAOB (0.40) HTR2AHTR2CCSNK2A2CSNK2A1CSNK2B
SCHEMBL6135605 0.83 CSNK2A2 (0.53) USP2HTR2ATSHRDRD3CSNK2A2
SCHEMBL6134614 0.80 DRD3 (0.47) USP2ALDH1A1TSHRDRD3CSNK2A2
Trifluoroacetic Acid SCHEMBL6132856 0.79 RAB9A (0.62) USP2ALDH1A1CSNK2A2CSNK2A1CSNK2B
SCHEMBL6132331 0.75 RAB9A (0.44) ALDH1A1LMNAMAPTRAB9AHRH3
Trifluoroacetic Acid SCHEMBL6134998 0.74 SIRT2 (0.40) ALDH1A1TSHRDRD3LMNAMAPT
SCHEMBL6134927 0.74 RAB9A (0.43) ALDH1A1LMNAMAPTRAB9AHRH3
SCHEMBL6134389 0.74 DRD3 (0.51) HTR2ADRD3DRD4DRD2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed
EP-1366066-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-12-03 EP disclosed
WO-2002072621-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 USP2 4776/4885ALDH1A1 3841/4885HTR2A 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.